CIAM
PHAT icon

Caitong International Asset Management’s Phathom Pharmaceuticals PHAT Stock Holding History

Caitong International Asset Management’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-28
Closed -$465 – 2946
2025
Q4 		$465 Buy
+28
New +$400 ﹤0.01% 1486
2025
Q2 		– Sell
-113
Closed -$709 – 2364
2025
Q1 		$709 Sell
113
-66
-37% -$401 ﹤0.01% 1669
2024
Q4 		$1.45K Buy
+179
New +$2.22K ﹤0.01% 1239

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Caitong International Asset Management's PHAT Position: Q1 2026 in Review

Caitong International Asset Management sold out of Phathom Pharmaceuticals (PHAT) in Q1 2026, closing a stake of 28 shares — an estimated $465 sold.

Caitong International Asset Management first reported a position in PHAT in Q4 2024 and held it in 3 quarters. The position peaked at $1.45K in Q4 2024. 174 funds tracked by Wall St. Rank hold PHAT as of Q1 2026.

  • Caitong International Asset Management reported no remaining Phathom Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Caitong International Asset Management sold 28 Phathom Pharmaceuticals shares in Q1 2026, an estimated $465.
  • Caitong International Asset Management first reported a position in Phathom Pharmaceuticals in Q4 2024 and held it in 3 quarters.
  • Caitong International Asset Management's Phathom Pharmaceuticals position peaked at $1.45K in Q4 2024.
  • 174 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.